Literature DB >> 26573835

Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.

Allison K Ehrlich1, Jamie M Pennington1, Xisheng Wang1, Diana Rohlman1, Sumit Punj1, Christiane V Löhr2, Matthew T Newman1, Siva K Kolluri1, Nancy I Kerkvliet3.   

Abstract

Aryl hydrocarbon receptor (AhR) activation by high-affinity ligands mediates immunosuppression in association with increased regulatory T cells (Tregs), making this transcription factor an attractive therapeutic target for autoimmune diseases. We recently discovered 10-chloro-7H-benzimidazo[2,1-a]benzo[de]iso-quinolin-7-one (10-Cl-BBQ), a nanomolar affinity AhR ligand with immunosuppressive activity and favorable pharmacologic properties. In this study, we tested the consequences of AhR activation in the NOD model. Oral 10-Cl-BBQ treatment prevented islet infiltration without clinical toxicity, whereas AhR-deficient NOD mice were not protected. Suppression of insulitis was associated with an increased frequency, but not total number, of Foxp3(+) Tregs in the pancreas and pancreatic lymph nodes. The requirement for Foxp3(+) cells in AhR-induced suppression of insulitis was tested using NOD.Foxp3(DTR) mice, which show extensive islet infiltration upon treatment with diphtheria toxin. AhR activation prevented the development of insulitis caused by the depletion of Foxp3(+) cells, demonstrating that Foxp3(+) cells are not required for AhR-mediated suppression and furthermore that the AhR pathway is able to compensate for the absence of Foxp3(+) Tregs, countering current dogma. Concurrently, the development of disease-associated CD4(+)Nrp1(+)Foxp3(-)RORγt(+) cells was inhibited by AhR activation. Taken together, 10-Cl-BBQ is an effective, nontoxic AhR ligand for the intervention of immune-mediated diseases that functions independently of Foxp3(+) Tregs to suppress pathogenic T cell development.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26573835      PMCID: PMC4684970          DOI: 10.4049/jimmunol.1501789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors.

Authors:  Majedah Abdul-Rasoul; Hessa Habib; Maha Al-Khouly
Journal:  Pediatr Diabetes       Date:  2006-04       Impact factor: 4.866

Review 3.  Role of beta-cells in type 1 diabetes pathogenesis.

Authors:  Béatrice Faideau; Etienne Larger; Françoise Lepault; Jean Claude Carel; Christian Boitard
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance.

Authors:  Takaaki Negishi; Yutaka Kato; Osamu Ooneda; Junsei Mimura; Tomonari Takada; Hidenori Mochizuki; Masayuki Yamamoto; Yoshiaki Fujii-Kuriyama; Shoji Furusako
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells.

Authors:  Castle J Funatake; Nikki B Marshall; Linda B Steppan; Dan V Mourich; Nancy I Kerkvliet
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

6.  2,3,7,8-Tetrachlorodibenzo-p-dioxin: failure to demonstrate toxicity in twenty-three cultured cell types.

Authors:  J C Knutson; A Poland
Journal:  Toxicol Appl Pharmacol       Date:  1980-07       Impact factor: 4.219

7.  A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response.

Authors:  Rafaèle Tordjman; Yves Lepelletier; Valérie Lemarchandel; Marie Cambot; Philippe Gaulard; Olivier Hermine; Paul-Henri Roméo
Journal:  Nat Immunol       Date:  2002-04-15       Impact factor: 25.606

8.  Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  N I Kerkvliet; L Baecher-Steppan; D M Shepherd; J A Oughton; B A Vorderstrasse; G K DeKrey
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

9.  T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.

Authors:  Nancy I Kerkvliet; David M Shepherd; Linda Baecher-Steppan
Journal:  Toxicol Appl Pharmacol       Date:  2002-12-01       Impact factor: 4.219

10.  In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Authors:  Qizhi Tang; Kammi J Henriksen; Mingying Bi; Erik B Finger; Greg Szot; Jianqin Ye; Emma L Masteller; Hugh McDevitt; Mark Bonyhadi; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  17 in total

1.  Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?

Authors:  Allison K Ehrlich; Nancy I Kerkvliet
Journal:  Curr Opin Toxicol       Date:  2017-02-01

2.  AhR activation increases IL-2 production by alloreactive CD4+ T cells initiating the differentiation of mucosal-homing Tim3+ Lag3+ Tr1 cells.

Authors:  Allison K Ehrlich; Jamie M Pennington; Susan Tilton; Xisheng Wang; Nikki B Marshall; Diana Rohlman; Castle Funatake; Sumit Punj; Edmond O'Donnell; Zhen Yu; Siva K Kolluri; Nancy I Kerkvliet
Journal:  Eur J Immunol       Date:  2017-09-15       Impact factor: 5.532

3.  The Aryl Hydrocarbon Receptor Modulates T Follicular Helper Cell Responses to Influenza Virus Infection in Mice.

Authors:  Cassandra L Houser; B Paige Lawrence
Journal:  J Immunol       Date:  2022-04-20       Impact factor: 5.426

4.  TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell Differentiation.

Authors:  Allison K Ehrlich; Jamie M Pennington; William H Bisson; Siva K Kolluri; Nancy I Kerkvliet
Journal:  Toxicol Sci       Date:  2018-02-01       Impact factor: 4.109

5.  The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.

Authors:  Edmond F O'Donnell; Hyo Sang Jang; Martin Pearce; Nancy I Kerkvliet; Siva Kumar Kolluri
Journal:  Oncotarget       Date:  2017-04-11

Review 6.  Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review.

Authors:  Xueyan Ding; Peng Bin; Wenwen Wu; Yajie Chang; Guoqiang Zhu
Journal:  Mediators Inflamm       Date:  2020-06-12       Impact factor: 4.711

Review 7.  Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells.

Authors:  Maxime Espi; Laetitia Koppe; Denis Fouque; Olivier Thaunat
Journal:  Toxins (Basel)       Date:  2020-05-06       Impact factor: 4.546

8.  Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.

Authors:  Ivana Stojanović; Tamara Saksida; Đorđe Miljković; Nada Pejnović
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

9.  Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome.

Authors:  Lisbeth A Boule; Catherine G Burke; Guang-Bi Jin; B Paige Lawrence
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

Review 10.  The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes.

Authors:  Tiantian Yue; Fei Sun; Chunliang Yang; Faxi Wang; Jiahui Luo; Ping Yang; Fei Xiong; Shu Zhang; Qilin Yu; Cong-Yi Wang
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.